4.3 Review

Epigenomics: The Science of No-Longer-Junk DNA. Why Study it in Chronic Kidney Disease?

期刊

SEMINARS IN NEPHROLOGY
卷 33, 期 4, 页码 354-362

出版社

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.semnephrol.2013.05.007

关键词

Kidney; epigenetics; cytosine methylation; enhancer; histones

资金

  1. National Institutes of Health (National Institute for Diabetes and Digestive and Kidney Diseases)
  2. American Diabetes Association
  3. Juvenile Diabetes Research Foundation

向作者/读者索取更多资源

Epigenetics refers to functionally relevant modifications of the genome that do not involve a change in the nucleotide sequence. Examples of such modifications are DNA methylation and histone modifications. Both modifications serve to regulate gene expression without altering the underlying DNA sequence. The epigenome encodes critical information to regulate gene expression. The cellular epigenome is established during development and differentiation and maintained during cell division. These instructions are different in each cell type; therefore, the epigenome is cell-type-specific. Nutrient availability and other environmental factors cause changes in the epigenome. Recent research suggests the critical contribution of the epigenome to the development of complex gene-environmental diseases including chronic kidney diseases. Published by Elsevier Inc.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据